Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Applied Therapeutics (APLT) Cash from Investing Activities (2023)

Historic Cash from Investing Activities for Applied Therapeutics (APLT) over the last 1 years, with Q1 2023 value amounting to $13.9 million.

  • Applied Therapeutics' Cash from Investing Activities changed N/A to $13.9 million in Q1 2023 from the same period last year, while for Dec 2023 it was $13.9 million, marking a year-over-year change of. This contributed to the annual value of $13.9 million for FY2023, which is 533.03% up from last year.
  • According to the latest figures from Q1 2023, Applied Therapeutics' Cash from Investing Activities is $13.9 million.
  • In the past 5 years, Applied Therapeutics' Cash from Investing Activities ranged from a high of $13.9 million in Q1 2023 and a low of $13.9 million during Q1 2023